Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Interviews.
- Who it may be relevant to
- Registry conditions: Pancreatic Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this research is to understand why some groups of people do not join clinical trials as much as others. These groups can include people from different racial or ethnic backgrounds, people with lower incomes, people who live in rural areas, and people who speak different languages. Investigators interview participants to learn about their experiences with clinical trials. By learning from them, investigators hope to find better ways to help more people learn about, join, and stay in clinical trials so that research is fair and helpful for everyone.
Detailed description
Primary Objectives:
The primary objective of this study is to comprehensively assess the barriers to and facilitators of interventional clinical trial enrollment via in-depth interview of participants with pancreatic cancer among diverse backgrounds. The primary outcome will be identification of specific opportunities for improvement to increase study enrollment.
The above aim is part of a long-term multi-armed quality improvement project with the goal of increasing clinical trial enrollment among minority individuals with pancreas cancer. Using the data gained from this project, investigators aim to implement and tailor interventions towards addressing these barriers in conjunction with current scientific evidence. While the QI project is separate from this IRB submission, data gained from this specific research study will be crucial towards steering further improvement efforts.
Interventions
- Other Interviews
Participants will be offered a 30 to 45-minute telephone or video in-depth interview at a specific time convenient to the participants.
Primary outcome measures
- Questionnaires/Surveys [Time frame: Through study completion; an average of 1 year]
Eligibility criteria
Inclusion criteria
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Males and females; Age ≥18
- Documented diagnosis of pancreatic cancer
- Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access)
Exclusion criteria
An individual who meets any of the following criteria will be excluded from participation in this study:
- Patients who speak a primary language other than English or Spanish
- Patients who are cognitively impaired
- Pregnant women
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
United States · 1 center
- UT MD Anderson — Houston
Identifiers
NCT: NCT07591480 · 2026-0019 · NCI-2026-02708